A Clinical Study Comparing Safety and Immunogenicity of bOPV of Bilthoven Biologicals

Clinical trial NCT02766816 · COMPLETED

Trial details

NCT number: NCT02766816
Sponsor: Bilthoven Biologicals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Response to Oral Polio Vaccine

Start date: 2016-06-08
Primary completion: 2018-02-14
Enrollment: 1120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.